Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2014-03-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal
NCT02871375
Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers
NCT01494545
Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use
NCT06308666
Dailies Total 1 Sphere Contact Lenses
NCT05239494
Clinical Assessment of a Daily Disposable Soft Silicone Hydrogel Contact Lens
NCT06044948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
16hrs/15mins
Delefilcon A contact lenses worn bilaterally (in both eyes) for 16 waking hours (1 day) in Period 1, followed by 15 minutes in Period 2. A fresh pair of lenses was dispensed for Period 2.
Delefilcon A contact lenses
Silicone hydrogel contact lenses
15mins/16hrs
Delefilcon A contact lenses worn bilaterally for 15 minutes in Period 1, followed by 16 waking hours (1 day) in Period 2. A fresh pair of lenses was dispensed for Period 2.
Delefilcon A contact lenses
Silicone hydrogel contact lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delefilcon A contact lenses
Silicone hydrogel contact lenses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adapted, current soft contact lens wearer.
* Requires contact lens powers within the specified range of -0.50 diopters (D) to -10.00D.
* Cylinder between 0.00D and -1.00D (inclusive) in both eyes at Visit 1 manifest refraction.
* Vision correctable to 20/25 or better in each eye at distance with study lenses.
* Willing to wear study lenses at least 16 waking hours in one day and attend all study visits.
* Able to be successfully fitted with study lenses.
Exclusion Criteria
* Use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator.
* Use of artificial tears and rewetting drops during the study.
* Monocular (only one eye with functional vision) or fit with only one lens.
* Any abnormal ocular condition observed during the Visit 1 slit lamp examination.
* History of herpetic keratitis, ocular surgery, or irregular cornea.
* Pregnant.
* Participation in any clinical study within 30 days of Visit 1.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa L. Zoota, MPH, CCRA
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-14-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.